GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stemtech Corp (OTCPK:STEK) » Definitions » Pre-Tax Income

STEK (Stemtech) Pre-Tax Income : $-5.24 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Stemtech Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Stemtech's pretax income for the three months ended in Sep. 2024 was $-1.17 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2024 was $-5.24 Mil. Stemtech's pretax margin was -113.47%.

During the past 4 years, Stemtech's highest Pretax Margin was -39.41%. The lowest was -187.26%. And the median was -137.47%.


Stemtech Pre-Tax Income Historical Data

The historical data trend for Stemtech's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stemtech Pre-Tax Income Chart

Stemtech Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
-1.73 -7.11 -8.54 -5.43

Stemtech Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.01 -1.86 -1.42 -0.78 -1.17

Competitive Comparison of Stemtech's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Stemtech's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stemtech's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stemtech's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Stemtech's Pre-Tax Income falls into.


;
;

Stemtech Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Stemtech's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-4.225+3.686+-4.893+0+-1.7763568394003E-15
=-5.43

Stemtech's Pretax Income for the quarter that ended in Sep. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.716+0.039+-0.494+0+0
=-1.17

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stemtech  (OTCPK:STEK) Pre-Tax Income Explanation

Stemtech's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-1.171/1.032
=-113.47%

During the past 4 years, Stemtech's highest Pretax Margin was -39.41%. The lowest was -187.26%. And the median was -137.47%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stemtech Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Stemtech's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Stemtech Business Description

Traded in Other Exchanges
N/A
Address
4851 Tamiami Trail North, Suite 200, Naples, FL, USA, 34103
Stemtech Corp is a nutraceutical company. Its products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood and migrate them into tissues, where perform their daily function of renewal for optimal health. It markets its products under the following brands: RCM System, stemrelease3, Stemflo MigraStem, OraStem (Oral Health Care), and D-Fuze. Geographically, it derives a majority of its revenue from the Americas.
Executives
Charles Stuart Arnold director 520 BRICKELL KEY DR #1607, MIAMI FL 33131
Mindshare Holdings, Inc. 10 percent owner 419 BOSTWICK LANE, GAITHERSBURG MD 20878
Darryl V Green director 300 SIXTH AVENUE, PITTSBURGH PA 15222
John William Meyer director 10370 USA TODAY WAY, MIRAMAR FL 33025
Benjamin Nathaniel Kaplan director 13005 CORONOADO LANE, NORTH MIAMI FL 33181